Pharmacokinetic Enhancers (Boosters)—Escort for Drugs against Degrading Enzymes and Beyond
نویسندگان
چکیده
منابع مشابه
Lignin-degrading enzymes
The substantial potential applications of lignin-degrading microbes and enzymes have spurred research on lignin biodegradation in recent years. As described here, that research has led to the discovery in the basidiomycete Phanerochaete chrysosporium of the first lignin-degrading enzymes and elucidation of their mode of action. A family of powerful extracellular peroxidase isoenzymes has been t...
متن کاملSingle microassay for matrix degrading enzymes.
Matrix degrading enzymes are implicated in several disease processes such as abdominal aortic aneurysms and emphysema, however, monitoring proteolytic activity in a single assay is not well-established. Numerous assays have been developed to measure matrix degrading enzymes, which use artificial substrates or substrates derived from natural substrate protein. We have recently developed an assay...
متن کاملDextran-degrading Enzymes from Molds1
Enzymes capable of degrading dextran, the polymer of glucose produced from sucrose by the action of Leuconostoc mesenteroides and related organisms, are potentially valuable for fundamental research as well as for practical application. Although the a-i ,6-glucopyranosidic linkage is present to the extent of 95 per cent or more in some easily obtainable dextrans, the only other known occurrence...
متن کاملCognitive enhancers (nootropics). Part 2: drugs interacting with enzymes. Update 2014.
Scientists working in the field of Alzheimer's disease and, in particular, cognitive enhancers are very productive. The review on Drugs interacting with Enzymes was accepted in August 2012. However, this field is very dynamic. New potential targets for the treatment of Alzheimer's disease were identified. This update describes drugs interacting with 60 enzymes versus 43 enzymes in the first pap...
متن کاملCognitive enhancers (nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. disease-modifying drugs.
Cognitive enhancers (nootropics) are drugs to treat cognition deficits in patients suffering from Alzheimer's disease, schizophrenia, stroke, attention deficit hyperactivity disorder, or aging. Cognition refers to a capacity for information processing, applying knowledge, and changing preferences. It involves memory, attention, executive functions, perception, language, and psychomotor function...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Scientia Pharmaceutica
سال: 2018
ISSN: 2218-0532
DOI: 10.3390/scipharm86040043